Event
Purdue Frederick guilty pleas (2007)
The Purdue Frederick Company pleaded guilty to felony misbranding of OxyContin; three executives pleaded guilty to a misdemeanor.
- Dates
- 10 May 2007
Connections 8
involved
- The Purdue Frederick Company pleaded guilty to felony misbranding OxyContin Primary record 1
- Michael Friedman pleaded guilty to a misdemeanor Primary record 1
- Howard Udell pleaded guilty to a misdemeanor Primary record 1
- Paul Goldenheim pleaded guilty to a misdemeanor Primary record 1
- John Brownlee U.S. Attorney who announced the pleas Primary record 1
- U.S. District Court, Western District of Virginia court in Abingdon where the pleas were entered Primary record 1
- Abingdon, Virginia where the pleas were entered Primary record 1
- Stamford, Connecticut Purdue’s headquarters, where new sales representatives were trained Primary record 1
Timeline 1 date
- 10 May 2007 Purdue Frederick guilty pleas (2007)
Proof 1 source
-
The Purdue Frederick Company, Inc. and Top Executives Plead Guilty to Misbranding OxyContin; Will Pay Over $600 Million, U.S. Attorney’s Office, Western District of Virginia, 10 May 2007.
Primary record
Archived copy
The Purdue Frederick Company, Inc., pleaded guilty to felony misbranding OxyContin with the intent to defraud and mislead.
President and Chief Operating Officer Michael Friedman, Executive Vice President and Chief Legal Officer Howard Udell, and former Executive Vice President of Worldwide Medical Affairs Paul D. Goldenheim, pleaded guilty to a misdemeanor charge of misbranding OxyContin.
John L. Brownlee, United States Attorney for the Western District of Virginia, and Virginia Attorney General Bob McDonnell announced today that The Purdue Frederick Company, Inc.
All the pleas were entered in United States District Court in Abingdon this morning.
during role-play training at Purdue’s headquarters in Stamford, Connecticut.
Page history 1 change
- Add 55 stories, each checked against its sources96e92fe6
Something wrong or missing? Tell us, with a source, or edit this page.